Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.
2.

On mosaics and melting pots: conceptual considerations of comparison and matching strategies.

Burack JA, Iarocci G, Flanagan TD, Bowler DM.

J Autism Dev Disord. 2004 Feb;34(1):65-73. Review.

PMID:
15098959
3.

Effects of anionic and nonionic polymers on fusion and binding of Sendai virus to human erythrocyte ghosts.

Wagner M, Flanagan TD, Ohki S.

Antiviral Res. 1998 Aug;39(2):113-27.

PMID:
9806488
4.

Fusion of Sendai virus and individual host cells and inhibition of fusion by lipophosphoglycan measured with image correlation spectroscopy.

Rasmusson BJ, Flanagan TD, Turco SJ, Epand RM, Petersen NO.

Biochim Biophys Acta. 1998 Sep 16;1404(3):338-52.

5.

Properties of lipoamino acids incorporated into membrane bilayers.

Epand RF, Infante MR, Flanagan TD, Epand RM.

Biochim Biophys Acta. 1998 Aug 14;1373(1):67-75.

6.

Probe transfer with and without membrane fusion in a fluorescence fusion assay.

Ohki S, Flanagan TD, Hoekstra D.

Biochemistry. 1998 May 19;37(20):7496-503.

PMID:
9585563
7.

Lipogastrins as potent inhibitors of viral fusion.

Epand RF, Moroder L, Lutz J, Flanagan TD, Nir S, Epand RM.

Biochim Biophys Acta. 1997 Jul 25;1327(2):259-68.

8.

Epidemiology of group C rotavirus infection in Western New York women of childbearing age.

Riepenhoff-Talty M, Morse K, Wang CH, Shapiro C, Roberts J, Welter M, Allen M, Evans MJ, Flanagan TD.

J Clin Microbiol. 1997 Feb;35(2):486-8.

9.

Glycophorin as a receptor for Sendai virus.

Wybenga LE, Epand RF, Nir S, Chu JW, Sharom FJ, Flanagan TD, Epand RM.

Biochemistry. 1996 Jul 23;35(29):9513-8.

PMID:
8755731
10.

Potent inhibition of viral fusion by the lipophosphoglycan of Leishmania donovani.

Miao L, Stafford A, Nir S, Turco SJ, Flanagan TD, Epand RM.

Biochemistry. 1995 Apr 11;34(14):4676-83.

PMID:
7718571
11.

The role of the ganglioside GD1a as a receptor for Sendai virus.

Epand RM, Nir S, Parolin M, Flanagan TD.

Biochemistry. 1995 Jan 24;34(3):1084-9.

PMID:
7827024
12.

Inhibition of membrane fusion by lysophosphatidylcholine.

Yeagle PL, Smith FT, Young JE, Flanagan TD.

Biochemistry. 1994 Feb 22;33(7):1820-7.

PMID:
8110784
13.
14.

Effect of anionic polymers on fusion of Sendai virus with human erythrocyte ghosts.

Ohki S, Arnold K, Srinivasakumar N, Flanagan TD.

Antiviral Res. 1992 Jun;18(2):163-77.

PMID:
1329648
15.
16.

Inhibition of Sendai virus fusion with phospholipid vesicles and human erythrocyte membranes by hydrophobic peptides.

Kelsey DR, Flanagan TD, Young JE, Yeagle PL.

Virology. 1991 Jun;182(2):690-702.

PMID:
1850923
17.
18.

Effect of dextran sulfate on fusion of Sendai virus with human erythrocyte ghosts.

Ohki S, Arnold K, Srinivasakumar N, Flanagan TD.

Biomed Biochim Acta. 1991;50(2):199-206.

PMID:
1652245
19.

Cholesterol sulfate inhibits the fusion of Sendai virus to biological and model membranes.

Cheetham JJ, Epand RM, Andrews M, Flanagan TD.

J Biol Chem. 1990 Jul 25;265(21):12404-9.

20.
21.
22.

Influence of dextran sulfate on the fusion of Sendai virus with liposomes.

Arnold K, Flanagan TD, Ohki S.

Biomed Biochim Acta. 1990;49(7):633-5.

PMID:
2177984
23.
24.

The interaction of Sendai virus glycoprotein-bearing recombinant vesicles with cell surfaces.

Al-Ahdal MN, Abidi TF, Flanagan TD.

Biochim Biophys Acta. 1986 Jan 29;854(2):157-68.

PMID:
3002466
25.

Immunoblotting and related techniques.

Flanagan TD.

J Allergy Clin Immunol. 1985 Oct;76(4):527-9. No abstract available.

PMID:
3902936
26.

Cytotoxic T-lymphocyte reactivity with individual Sendai virus glycoproteins.

Al-Ahdal MN, Nakamura I, Flanagan TD.

J Virol. 1985 Apr;54(1):53-7.

29.

Lymphoid cell killing by human cytomegalovirus.

Riepenhoff-Talty M, Flanagan TD.

Arch Virol. 1982;73(1):51-60.

PMID:
6289777
30.

Central nervous system infections; etiologic and epidemiologic observations in New York State, 1978-1979.

Flanagan TD, Deibel R.

N Y State J Med. 1981 Aug;81(9):1346-53. No abstract available.

PMID:
6943444
31.

Response of lymphocytes from multiple sclerosis patients to murine brain extract.

Wicher V, Olszewski W, Flanagan TD, Milgrom F.

Immunol Commun. 1980;9(5):465-74.

PMID:
6159303
32.

Central nervous system infections. Etiologic and epidemiologic observations in New York State, 1976-1977.

Deibel R, Flanagan TD.

N Y State J Med. 1979 Apr;79(5):689-95. No abstract available.

PMID:
286166
33.

Properties of herpesvirus-specific thymidine kinase, DNA polymerase and DNase and their implication in the development of specific antiherpes agents.

Cheng YC, Hoffmann PJ, Ostrander M, Grill S, Caradonna S, Tsou J, Chen JY, Gallagher MR, Flanagan TD.

Adv Ophthalmol. 1979;38:173-86. No abstract available.

PMID:
230714
35.

Central nervous system infections. Etiologic and epidemiologic observations in New York State, 1975.

Deibel R, Flanagan TD, Smith V.

N Y State J Med. 1977 Aug;77(9):1398-1404. No abstract available.

PMID:
267829
37.

Tumorigenicity of Epstein-Barr virus (EBV)-transformed lymphoid line cells in autologous squirrel monkeys.

Leibold W, Huldt G, Flanagan TD, Andersson M, Dalens M, Wright DH, Voller A, Klein G.

Int J Cancer. 1976 Apr 15;17(4):533-41.

PMID:
179960
39.

Central nervous system infections in New York State. Etiologic and epidemiologic observations, 1974.

Deibel R, Flanagan TD, Smith V.

N Y State J Med. 1975 Nov;75(13):2337-42. No abstract available.

PMID:
1059007
42.

Induction of Epstein-Barr virus-associated nuclear antigen during in vitro transformation of human lymphoid cells.

Leibold W, Flanagan TD, Menezes J, Klein G.

J Natl Cancer Inst. 1975 Jan;54(1):65-8.

PMID:
163326
43.

Production of macrophage migration inhibition factors by virus-infected cell cultures.

Flanagan TD, Yoshida T, Cohen S.

Infect Immun. 1973 Aug;8(2):145-50.

44.

Immunocyte response to experimental mumps virus infection in Rhesus monkeys.

Genco RJ, Flanagan TD, Emmings FG.

Infect Immun. 1973 Apr;7(4):520-5.

45.

Leukotactic factors elaborated by virus-infected tissues.

Ward PA, Cohen S, Flanagan TD.

J Exp Med. 1972 May 1;135(5):1095-103.

46.

Response to experimental infection with mumps virus in rhesus monkeys.

Flanagan TD, Andrada JA, Barron AL, Witebsky E.

Infect Immun. 1971 May;3(5):642-7.

47.

Virological investigations of chickens with spontaneous autoimmune thyroiditis. I. Isolation and transmission studies.

Flanagan TD, Barron AL, Kite JH, Witebsky E.

Avian Dis. 1970 Nov;14(4):613-6. No abstract available.

PMID:
4323093
48.

Plaque formation by mumps virus and inhibition by antiserum.

Flanagan TD, Barron AL.

Appl Microbiol. 1970 Feb;19(2):360-6.

49.

[Multiplication of mumps virus in organotypical cultures of monkey testes].

Bigazzi PL, Barron AL, Flanagan TD, Andrada JA, Witebsky E.

Prog Immunobiol Stand. 1970;4:650-6. Italian. No abstract available.

PMID:
4991596
50.

Immune response of chickens to six strains of Newcastle disease virus as measured by hemagglutination-inhibition test.

Chang PW, Yates VJ, Pendleton JA, Flanagan TD.

Avian Dis. 1969 Feb;13(1):46-52. No abstract available.

PMID:
5813248

Supplemental Content

Loading ...
Support Center